» Articles » PMID: 30012131

Engineering of Escherichia Coli for Krebs Cycle-dependent Production of Malic Acid

Overview
Publisher Biomed Central
Date 2018 Jul 18
PMID 30012131
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Malate is a C4-dicarboxylic acid widely used as an acidulant in the food and beverage industry. Rational engineering has been performed in the past for the development of microbial strains capable of efficient production of this metabolite. However, as malate can be a precursor for specialty chemicals, such as 2,4-dihydroxybutyric acid, that require additional cofactors NADP(H) and ATP, we set out to reengineer Escherichia coli for Krebs cycle-dependent production of malic acid that can satisfy these requirements.

Results: We found that significant malate production required at least simultaneous deletion of all malic enzymes and dehydrogenases, and concomitant expression of a malate-insensitive PEP carboxylase. Metabolic flux analysis using C-labeled glucose indicated that malate-producing strains had a very high flux over the glyoxylate shunt with almost no flux passing through the isocitrate dehydrogenase reaction. The highest malate yield of 0.82 mol/mol was obtained with E. coli Δmdh Δmqo ΔmaeAB ΔiclR ΔarcA which expressed malate-insensitive PEP carboxylase Ppc and NADH-insensitive citrate synthase GltA. We also showed that inactivation of the dicarboxylic acid transporter DcuA strongly reduced malate production arguing for a pivotal role of this permease in malate export.

Conclusions: Since more NAD(P)H and ATP cofactors are generated in the Krebs cycle-dependent malate production when compared to pathways which depend on the function of anaplerotic PEP carboxylase or PEP carboxykinase enzymes, the engineered strain developed in this study can serve as a platform to increase biosynthesis of malate-derived metabolites such as 2,4-dihydroxybutyric acid.

Citing Articles

Metabolomics Revealed the Effects of L. Saponins on Diabetic Hyperglycemia and Wound Healing in Mice.

Zhao D, Luo Z, Li S, Liu S, Wang C Foods. 2024; 13(19).

PMID: 39410199 PMC: 11476179. DOI: 10.3390/foods13193163.


Cofactor Metabolic Engineering of for Aerobic L-Malate Production with Lower CO Emissions.

Jiang Z, Jiang Y, Wu H, Zhang W, Xin F, Ma J Bioengineering (Basel). 2023; 10(8).

PMID: 37627766 PMC: 10451681. DOI: 10.3390/bioengineering10080881.


Toxic effect and inability of L-homoserine to be a nitrogen source for growth of resolved by a combination of evolution engineering and omics analyses.

Alkim C, Farias D, Fredonnet J, Serrano-Bataille H, Herviou P, Picot M Front Microbiol. 2022; 13:1051425.

PMID: 36583047 PMC: 9792984. DOI: 10.3389/fmicb.2022.1051425.


Engineering the glyoxylate cycle for chemical bioproduction.

Yang P, Liu W, Chen Y, Gong A Front Bioeng Biotechnol. 2022; 10:1066651.

PMID: 36532595 PMC: 9755347. DOI: 10.3389/fbioe.2022.1066651.


Designing Microbial Cell Factories for the Production of Chemicals.

Cho J, Kim G, Eun H, Moon C, Lee S JACS Au. 2022; 2(8):1781-1799.

PMID: 36032533 PMC: 9400054. DOI: 10.1021/jacsau.2c00344.


References
1.
Chi Z, Wang Z, Wang G, Khan I, Chi Z . Microbial biosynthesis and secretion of l-malic acid and its applications. Crit Rev Biotechnol. 2014; 36(1):99-107. DOI: 10.3109/07388551.2014.924474. View

2.
Golby P, Kelly D, Guest J, Andrews S . Transcriptional regulation and organization of the dcuA and dcuB genes, encoding homologous anaerobic C4-dicarboxylate transporters in Escherichia coli. J Bacteriol. 1998; 180(24):6586-96. PMC: 107762. DOI: 10.1128/JB.180.24.6586-6596.1998. View

3.
Song C, Kim D, Choi S, Jang J, Lee S . Metabolic engineering of Escherichia coli for the production of fumaric acid. Biotechnol Bioeng. 2013; 110(7):2025-34. DOI: 10.1002/bit.24868. View

4.
Stokell D, Donald L, Maurus R, Nguyen N, Sadler G, Choudhary K . Probing the roles of key residues in the unique regulatory NADH binding site of type II citrate synthase of Escherichia coli. J Biol Chem. 2003; 278(37):35435-43. DOI: 10.1074/jbc.M302786200. View

5.
Walther T, Topham C, Irague R, Auriol C, Baylac A, Cordier H . Construction of a synthetic metabolic pathway for biosynthesis of the non-natural methionine precursor 2,4-dihydroxybutyric acid. Nat Commun. 2017; 8:15828. PMC: 5481828. DOI: 10.1038/ncomms15828. View